A prominent healthcare enterprise dedicated to enhancing individuals’ well-being, announced today that the Kansas Department of Administration has chosen its subsidiary, Sunflower Health Plan (Sunflower), based in Kansas, to continue…
Managed Health Services (MHS), a longstanding managed care entity in Indiana, operating under Centene Corporation (NYSE: CNC), has unveiled the launch of MHS Serves, a pioneering $12 million health equity…
Prevention—activities designed to avoid substance misuse and mitigate its health and social consequences—is crucial for promoting mental health, preventing substance misuse, and supporting recovery efforts. CVS Health® is committed to…
Fresenius, a global healthcare conglomerate, has announced its decision to divest from Investment Company Vamed following the sale of Vamed’s rehabilitation business. An Austrian consortium comprising construction companies Porr and…
Quarter 2 of Fiscal Year 2024: Outlook for Fiscal Year 2024: Bernd Montag, CEO of Siemens Healthiness AG, states: “The Healthineers team has continued its successful growth trajectory, even relative…
A recent survey conducted by CVS Health® in collaboration with Morning Consult has revealed a growing concern among adults regarding mental health issues, with rates steadily increasing across the nation.…
Today, KKR, a prominent global investment firm, revealed the finalization of agreements whereby KKR-managed funds will purchase Healthium Medtech Ltd. (“Healthium”), a top Indian medical devices company, from an affiliate…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech firm focused on pioneering treatments for urothelial and specialty cancers, has unveiled findings from a fresh examination of the ATLAS trial. This analysis…
UroGen Pharma Ltd. (Nasdaq: URGN), specializing in innovative treatments for urothelial and specialty cancers, highlights findings from a sub-analysis of real-world patient data on JELMYTO (mitomycin) for pyelocalyceal solution. Presented…
Axonics, Inc. (Nasdaq: AXNX), a medical technology firm specializing in innovative and minimally invasive products for bladder and bowel dysfunction treatment, announced its financial results for the three months ending…
ICON plc (NASDAQ: ICLR), a top-tier healthcare intelligence and clinical research organization, has announced the pricing of a $2 billion SEC-registered bond offering. The offering includes $750 million 5.809% Senior…
Merrimack Pharmaceuticals (NASDAQ: MACK) has notified NASDAQ of its intention to delist its securities, pending stockholder approval of the Plan of Dissolution at the scheduled Special Meeting on May 10,…